Cost effectiveness and resource allocation : C/E1478-7547
2007

Cost-effectiveness of Tipranavir in HIV Treatment

Sample size: 1000 publication 10 minutes Evidence: moderate

Author Information

Author(s): Hubben Gijs AA, Bos Jasper M, Veltman-Starkenburg Christa A, Stegmeijer Simon, Finnern Henrik W, Kappelhoff Bregt S, Simpson Kit N, Tramarin Andrea, Postma Maarten J

Primary Institution: University Center for Pharmacy, University of Groningen, The Netherlands

Hypothesis

Is the cost-effectiveness of tipranavir better than that of comparator protease inhibitors in HIV patients previously exposed to antiretroviral therapy?

Conclusion

Tipranavir is estimated to be cost-effective compared to comparator protease inhibitors for HIV treatment in the Netherlands.

Supporting Evidence

  • The TPV/r regimen resulted in 0.52 life years gained compared to CPI/r.
  • The incremental cost-effectiveness ratio for TPV/r was approximately €42,500 per QALY.
  • Patients receiving TPV/r had a higher accumulated effect of 6.31 QALYs compared to 5.80 QALYs for CPI/r.
  • The total cost per patient for TPV/r was €167,200 compared to €145,400 for CPI/r.

Takeaway

This study looks at how much it costs to help HIV patients live longer and healthier lives with a new medicine called tipranavir compared to an older one.

Methodology

A 3-stage Markov model was used to compare costs and effects of two treatment regimens over a lifetime for 1000 patients.

Potential Biases

Potential bias due to reliance on data from a clinical trial with primarily non-Dutch participants.

Limitations

The model's transition probabilities were based on a US cohort, which may not fully represent the Dutch population.

Participant Demographics

HIV-1 infected patients previously treated with antiretroviral therapy in the Netherlands.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1186/1478-7547-5-15

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication